MedPath

To compare butorphanol and buprenorphine with levo-bupivacaine for post-operative analgesia

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/08/056741
Lead Sponsor
Rohilkhand Medical College And Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade I and II.

No other associated cardiovascular/ respiratory disease

Exclusion Criteria

Patient with known hypersensitivity to local anaesthetics.

Patients with opioids addiction.

Patient with any local infection at site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesia <br/ ><br> <br/ ><br>Time of First onset of pain and time of first request for analgesia <br/ ><br>Timepoint: In Postoperative ward, the patient will be assessed for the presence and severity of pain at rest and on movement by VAS, nausea, vomiting and any other side effects at intervals of 2, 4, 6, 8, 12, 24 hours. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Hemodynamic and Respiratory stability <br/ ><br> <br/ ><br>Any side effects or complications of study drugs and blocks <br/ ><br>Timepoint: The vitals heart rate NIBP & SPO2 will be recording for 30 minutes and at 2 4 6 8 12 24 hours postoperatively
© Copyright 2025. All Rights Reserved by MedPath